Abstract
The rise of generative AI (GenAI) technology is revolutionizing firm operations and supply chain management, profoundly influencing firms within the GenAI supply chain network. While a few emerging studies have explored the impact of GenAI initiatives on firms’ stock performance, it remains unclear how such disruptive technology initiatives affect the stock price movements of their supply chain partners. This paper empirically investigates the impact of firms’ GenAI initiatives on the abnormal stock returns of their suppliers by analyzing data on news, supply chain relationships, and daily stock prices. The analysis indicates that, on average, a firm's GenAI announcement leads to a positive abnormal return of 0.27% for its suppliers on the announcement day, with additional evidence of sustained long-term value creation. Heterogeneity analyses reveal that this spillover effect is more pronounced among suppliers with higher R&D intensity, stronger sales growth, closer geographic proximity to the focal firm, and operations in less competitive industries. Furthermore, the positive abnormal returns are significantly greater when the GenAI initiative pertains to product innovation rather than process improvement. Our findings have important implications for supply chain stakeholders navigating the adoption of GenAI technologies.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
